Jove
Visualize
Contact Us

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

9.2K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.2K
The Nucleolus02:55

The Nucleolus

9.4K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
9.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Abnormal Proliferation02:23

Abnormal Proliferation

4.7K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

7.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
7.7K
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

7.7K
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
7.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-stoichiometry and electrochemical properties of lithiated iron hydroxysulfides.

Dalton transactions (Cambridge, England : 2003)·2024
Same author

Expression of Toxin Receptors on Cell Surfaces in Transdifferentiating Cultures of Neural Retina: (chick embryo neural retina/transdifferentiation/neuronal cell surface toxin receptors/δ crystallin/double fluorescent labelling).

Development, growth & differentiation·2023
Same author

A single-center comparison of our initial experiences in treating penile and urethral cancer with video-endoscopic inguinal lymphadenectomy (VEIL) and later experiences in melanoma cases.

Frontiers in surgery·2022
Same author

Targeting the "undruggable": RNA-binding proteins in the spotlight in cancer therapy.

Seminars in cancer biology·2022
Same author

Insights into new mechanisms and models of cancer stem cell multidrug resistance.

Seminars in cancer biology·2019
Same author

Silencing of the transcriptional factor ZEB1 alters the steroidogenic pathway, and increases the concentration of testosterone and DHT in DU145 cells.

Oncology reports·2018
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 4, 2025

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture
10:34

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture

Published on: July 22, 2016

23.9K

RNA-binding proteins: Underestimated contributors in tumorigenesis.

Y Zhao1, C Mir1, Y Garcia-Mayea1

  • 1Biomedical Research in Cancer Stem Cells Group, Vall d'Hebron Research Institute (VHIR), Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.

Seminars in Cancer Biology
|February 6, 2022
PubMed
Summary

RNA-binding proteins (RBPs) regulate gene expression by controlling mRNA stability. Mutations in RBPs significantly impact cancer development, offering potential prognostic and diagnostic markers for cancer patients.

Keywords:
CancerDiagnosisPrognosisRNA-binding proteins (RBPs)Therapy

More Related Videos

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

6.8K
Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.3K

Related Experiment Videos

Last Updated: Oct 4, 2025

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture
10:34

Detection of RNA-binding Proteins by In Vitro RNA Pull-down in Adipocyte Culture

Published on: July 22, 2016

23.9K
Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins
11:34

Exploring Sequence Space to Identify Binding Sites for Regulatory RNA-Binding Proteins

Published on: August 9, 2019

6.8K
Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells
11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.3K

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Genetics

Background:

  • Messenger RNA (mRNA) stability is a key regulator of gene expression, influenced by processes like export, translation, splicing, cleavage, and capping.
  • RNA-binding proteins (RBPs) modulate mRNA stability, thereby affecting diverse cellular functions.
  • RBPs play increasingly recognized roles in tumorigenesis, influencing cancer prognosis, diagnosis, and treatment strategies.

Purpose of the Study:

  • To present a model illustrating how mutations in RBPs contribute to tumorigenesis.
  • To consolidate current understanding of the molecular mechanisms through which RBPs regulate cancer.
  • To highlight RBPs with significant potential as prognostic and diagnostic factors in cancer patients.

Main Methods:

  • Literature review and synthesis of existing research on RBPs in cancer.
  • Analysis of molecular mechanisms linking RBP function to cancer-related processes.
  • Identification and discussion of RBPs with established roles in cancer prognosis and diagnosis.

Main Results:

  • RBPs are implicated in fundamental cancer hallmarks including apoptosis, epithelial-mesenchymal transition (EMT), DNA repair, autophagy, cell proliferation, immune response, and metabolism.
  • Specific RBPs interact with oncogenes and tumor suppressor genes, underscoring their critical role in cancer.
  • Numerous RBPs have been identified as potential biomarkers for cancer diagnosis and prognosis.

Conclusions:

  • RBP mutations are pivotal in driving tumorigenesis through dysregulation of gene expression.
  • Understanding RBP molecular mechanisms provides insights into cancer development and progression.
  • RBPs represent a promising class of molecules for developing novel cancer diagnostics and therapeutics.